{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:18:19Z","timestamp":1768886299587,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009744","name":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmcl.2020.127696","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T22:00:34Z","timestamp":1605823234000},"page":"127696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Development of pyrimidone D1 dopamine receptor positive allosteric modulators"],"prefix":"10.1016","volume":"31","author":[{"given":"Kathryn D.","family":"Luderman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Benjamin Free","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie L.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Aub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Sibley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin J.","family":"Frankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2020.127696_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bmcl.2020.127696_b0010","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1523\/JNEUROSCI.3987-03.2004","article-title":"Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation","volume":"24","author":"Castner","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmcl.2020.127696_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","article-title":"The neuropsychopharmacology of fronto-executive function: monoaminergic modulation","volume":"32","author":"Robbins","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.bmcl.2020.127696_b0020","doi-asserted-by":"crossref","unstructured":"Arnsten AFT, Vijayragavan S, Wang M, Gamo NJ, Paspalas CD. Dopamine\u2019s Influence on Prefrontal Cortical Cognition: Actions and Circuits in Behaving Primates, in Dopamine Handbook 2009, (Iversen L.L. ISD, Dunnett S.B., Bjorklund A. ed) pp 230\u2013248, Oxford University Press, New York, NY.","DOI":"10.1093\/acprof:oso\/9780195373035.003.0016"},{"key":"10.1016\/j.bmcl.2020.127696_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nn1846","article-title":"Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory","volume":"10","author":"Vijayraghavan","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmcl.2020.127696_b0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3565(24)37594-9","article-title":"Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency","volume":"286","author":"Lewis","year":"1998","journal-title":"J Pharmacol Exper Therapeut"},{"key":"10.1016\/j.bmcl.2020.127696_b0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neuropharm.2008.02.011","article-title":"Dopamine D1 vs. D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1\/2 and GluR1-AMPA signaling","volume":"54","author":"O'Sullivan","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmcl.2020.127696_b0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/CS20070018","article-title":"The dopaminergic system in hypertension","volume":"112","author":"Zeng","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.bmcl.2020.127696_b0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2020.127696_b0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/acs.jmedchem.8b01767","article-title":"Novel strategies to activate the dopamine D1 receptor: recent advances in orthosteric agonism and positive allosteric modulation","volume":"62","author":"Hall","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127696_b0055","unstructured":"Beadle CD, Coates DA, Hao J et al., 3,4-Dihydroisoquinolin-2(1H)-yl compounds. 2014, WO 2014\/193781 A1, 1\u201390."},{"key":"10.1016\/j.bmcl.2020.127696_b0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/jpet.115.224071","article-title":"Discovery of D1 dopamine receptor positive allosteric modulators: characterization of pharmacology and identification of residues that regulate species selectivity","volume":"354","author":"Lewis","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2020.127696_b0065","article-title":"Tetrahydroisoquinoline derivatives","author":"Ates","year":"2017","journal-title":"PCT Int Appl"},{"key":"10.1016\/j.bmcl.2020.127696_b0070","unstructured":"Kawahami S, Imaizumi T, Masuda N, Kunikawa S, Morita M, Yarimizu J. Imidazodiazepine compounds. U.S. Patent 2018, 20180185383."},{"key":"10.1016\/j.bmcl.2020.127696_b0075","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1021\/acs.jmedchem.9b01234","volume":"62","author":"Hao","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2020.127696_b0080","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1124\/mol.118.113175","article-title":"Identification of positive allosteric modulators of the D1 dopamine receptor that act at diverse binding sites","volume":"94","author":"Luderman","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127696_b0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1124\/mol.118.112649","article-title":"Intracellular binding site for a positive allosteric modulator of the dopamine D1 receptor","volume":"94","author":"Wang","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2020.127696_b0090","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.tetlet.2013.02.058","article-title":"An efficient protocol for the preparation of amides by copper-catalyzed reactions between nitriles and amines in water","volume":"54","author":"Li","year":"2013","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2020.127696_b0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/jo00867a017","article-title":"Chemistry of 2H-3,1-benzoxazine-2,4-(1H)-dione (isatoic anhydride). 2. Reactions with thiopseudoureas and carbanions","volume":"41","author":"Coppola","year":"1976","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2020.127696_b0100","first-page":"947","article-title":"Comparative study on conventional heating, ultrasonication and microwave assisted synthesis of 2-amino-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carbonitriles","volume":"7","author":"Khoramdelan","year":"2017","journal-title":"Heterocyclic Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X20308076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:37:55Z","timestamp":1760773075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X20308076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":20,"alternative-id":["S0960894X20308076"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127696","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of pyrimidone D1 dopamine receptor positive allosteric modulators","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2020.127696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127696"}}